^
Phase 1
Olema Pharmaceuticals, Inc.
Recruiting
Last update posted :
10/03/2024
Initiation :
08/31/2022
Primary completion :
05/20/2026
Completion :
06/30/2026
HER-2
|
HER-2 negative
|
everolimus • Piqray (alpelisib) • Kisqali (ribociclib) • palazestrant (OP-1250)
Phase 3
Olema Pharmaceuticals, Inc.
Recruiting
Last update posted :
05/31/2024
Initiation :
11/16/2023
Primary completion :
06/30/2026
Completion :
09/30/2027
HER-2 • ER
|
HER-2 negative • ESR1 mutation
|
fulvestrant • letrozole • anastrozole • exemestane • palazestrant (OP-1250)